SCHEMBL8291394

SCHEMBL8291394

CC(C)(C)OC(=O)c1ccc(NCCN2CCCCC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.51
GLA P06280 1/20 0.51
ATM Q13315 1/20 0.51
ALDH1A1 P00352 1/20 0.48
RAB9A P51151 1/20 0.48
ACHE P22303 1/20 0.46
BACE1 P56817 1/20 0.46
EPHX2 P34913 1/20 0.46
HTR1A P08908 2/20 0.45
HTR7 P34969 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
CD274 Q9NZQ7 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ESRRG P62508 2/20 0.45
AURKA O14965 1/20 0.45
POLB P06746 1/20 0.44
CYP2D6 P10635 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5068134 0.99 NPSR1 (0.49) NPSR1GLAATMALDH1A1RAB9A
SCHEMBL27639228 0.86 NPSR1 (0.47) NPSR1GLAATMALDH1A1RAB9A
SCHEMBL1065672 0.81 EPHX2 (0.47) NPSR1GLAATMALDH1A1RAB9A
SCHEMBL1068474 0.79 ESRRG (0.54) NPSR1ALDH1A1EPHX2KDM4EESR1
SCHEMBL30969317 0.78 TNIK (0.51) NPSR1GLAATMALDH1A1EPHX2
SCHEMBL22661373 0.78 POLB (0.50) ALDH1A1RAB9AACHEHTR1AKDM4E
SCHEMBL5350540 0.78 ESRRG (0.52) NPSR1ALDH1A1RAB9AEPHX2KDM4E
SCHEMBL3689873 0.77 HRH3 (0.55) ALDH1A1KDM4ECYP2C9
SCHEMBL28176279 0.77 HRH3 (0.55) ALDH1A1KDM4ECYP2C9
SCHEMBL9809366 0.76 POLB (0.49) ALDH1A1RAB9AACHEKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868205-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-7868205-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2011-01-11 US disclosed
US-20080132459-A1 Inhibitors of Histone Deacetylase METHYLGENE, INC. (CA) 2008-06-05 US disclosed
US-20080132459-A1 Inhibitors of Histone Deacetylase METHYLGENE, INC. (CA) 2008-06-05 US disclosed
WO-2005030704-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132459-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 NPSR1 4455/4885GLA 402/4885ATM 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.